Laxabon

Polyethylene glycol (macrogol), the active ingredient in Laxabon, is an osmotic laxative presented as an oral solution for oral use. It is indicated for the relief of constipation in adults and children. GNH USA supplies Laxabon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Laxabon, an osmotic laxative, is used to manage constipation by increasing water content in the intestinal lumen.

Constipation: softens stool and promotes regular bowel movements in occasional or chronic cases. Opioid‑induced constipation: alleviates reduced gastrointestinal motility caused by opioid therapy. Functional constipation: improves stool frequency and consistency in patients with functional bowel disorders.

Laxabon may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal bloating or distension - Flatulence or gas - Nausea or mild stomach upset - Diarrhea or loose stools - Headache - Mild abdominal cramping

Serious or Rare Side Effects: - Severe electrolyte imbalance (e.g., hyponatremia, hypokalemia) - Marked dehydration - Allergic reactions including rash, itching, or anaphylaxis - Persistent severe abdominal pain - Rectal bleeding or severe gastrointestinal irritation

Before using Laxabon, consider the following safety measures. - Renal function assessment: evaluate kidney status, especially in patients with renal impairment. - Electrolyte monitoring: check serum electrolytes in prolonged or high‑volume use. - Caution in the elderly: increased risk of dehydration and electrolyte shifts. - Avoid in bowel obstruction or perforation: contraindicated where intestinal blockage exists. - Do not exceed prescribed volume: follow prescriber instructions to prevent over‑hydration. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Laxabon can interact with other medications that affect fluid or electrolyte balance.

Major Interactions (Avoid): - Concurrent use of other osmotic laxatives: may cause excessive fluid loss. - Mineral oil: can impair absorption of fat‑soluble vitamins and increase risk of steatorrhea. - High‑dose electrolyte solutions: may lead to dangerous electrolyte disturbances.

Moderate Interactions (Monitor Closely): - Diuretics: monitor for additive electrolyte depletion. - Antacids containing sodium or potassium: watch for cumulative electrolyte load. - NSAIDs: increased risk of gastrointestinal irritation. - ACE inhibitors or ARBs: potential for altered potassium levels.